Bioton S.A. - Asset Resilience Ratio

Latest as of December 2017: 0.01%

Bioton S.A. (BIO) has an Asset Resilience Ratio of 0.01% as of December 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

zł163.00K

≈ $44.86K USD Cash + Short-term Investments

Total Assets

zł1.14 Billion

≈ $314.29 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2019)

This chart shows how Bioton S.A.'s Asset Resilience Ratio has changed over time. Check how strategically is Bioton S.A.'s equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Bioton S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see BIO stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	zł0.00	0%
Short-term Investments	zł163.00K	0.01%
Total Liquid Assets	zł163.00K	0.01%

Asset Resilience Insights

Limited Liquidity: Bioton S.A. maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Bioton S.A. Industry Peers by Asset Resilience Ratio

Compare Bioton S.A.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Akero Therapeutics Inc NASDAQ:AKRO	Biotechnology	55.87%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Immunitybio Inc NASDAQ:IBRX	Biotechnology	38.07%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Bioton S.A. (2005–2019)

The table below shows the annual Asset Resilience Ratio data for Bioton S.A..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2019-12-31	0.20%	zł1.72 Million ≈ $474.19K	zł881.42 Million ≈ $242.58 Million	-2.28pp
2016-12-31	2.47%	zł32.02 Million ≈ $8.81 Million	zł1.30 Billion ≈ $356.45 Million	+1.92pp
2015-12-31	0.56%	zł6.95 Million ≈ $1.91 Million	zł1.25 Billion ≈ $344.03 Million	+0.53pp
2013-12-31	0.03%	zł491.00K ≈ $135.13K	zł1.89 Billion ≈ $520.37 Million	-0.71pp
2011-12-31	0.73%	zł14.83 Million ≈ $4.08 Million	zł2.02 Billion ≈ $557.19 Million	-0.87pp
2010-12-31	1.61%	zł25.42 Million ≈ $7.00 Million	zł1.58 Billion ≈ $435.30 Million	+0.72pp
2009-12-31	0.89%	zł14.32 Million ≈ $3.94 Million	zł1.60 Billion ≈ $441.67 Million	-1.35pp
2008-12-31	2.24%	zł46.35 Million ≈ $12.76 Million	zł2.06 Billion ≈ $568.26 Million	+0.87pp
2007-12-31	1.37%	zł21.23 Million ≈ $5.84 Million	zł1.55 Billion ≈ $425.52 Million	-5.08pp
2006-12-31	6.46%	zł64.01 Million ≈ $17.62 Million	zł991.63 Million ≈ $272.91 Million	+6.00pp
2005-12-31	0.46%	zł1.65 Million ≈ $452.73K	zł358.12 Million ≈ $98.56 Million	--

pp = percentage points

About Bioton S.A.

WAR:BIO Poland Biotechnology

Market Cap

$90.03 Million

zł327.14 Million PLN

Market Cap Rank

#19499 Global

#157 in Poland

Share Price

zł3.81

Change (1 day)

-0.52%

52-Week Range

zł3.74 - zł4.55

All Time High

zł15.39